ASP5834, a novel pan-KRAS degrader, shows potent anti-tumor activity in KRAS mutant cancer models (EORTC-NCI-AACR 2026) - Sep 11, 2026 - Abstract #326; PB-118; Pres time: Nov 20, 2026; Location: Exhibition Hall; "Abstract will be available as of 4 November (with consent of the author)"
Preclinical • Oncology • KRAS
|